Literature DB >> 27233786

[The Choosing Wisely Initiative of the German Society of Internal Medicine : Recommendations of the German Society for Endocrinology and the German Society for Geriatrics].

J Feldkamp1, M Schott2, M Gogol3, M Quinkler4, M Blüher5, S Diederich6, M Reincke7.   

Abstract

POSITIVE RECOMMENDATIONS: A. After osteoporotic fractures in the elderly, as a rule specific antiosteoporotic therapy should be initiated. a. Osteoporosis as a disease of the elderly should be diagnosed and treated (recommendation of the German Society for Geriatrics). B. All patients with diabetes mellitus should complete a specific diabetes training program when antidiabetic drug medication is initiated. C. In Germany, all pregnant women should be advised to undertake iodine supplementation. D. Endocrine causes of hypertension should be ruled out in younger patients and in patients on multiple antihypertensive drugs. E. All unclear cases of hypercalcemia should be clarified. NEGATIVE RECOMMENDATIONS: A. Testosterone substitution therapy should not be initiated on the basis of only one measurement of a reduced testosterone level without clinical signs and clarification of the underlying cause. B. Imaging procedures should only be used after the existence of hormonal disease has been confirmed. C. Sonographic screening for thyroid disease is not advised in the elderly. D. Long-term therapy with levothyroxine for nodular goiter should be avoided. E. In relevant stress situations hydrocortisone replacement therapy should not be continued without dose adjustment in patients with adrenal or pituitary insufficiency.

Entities:  

Keywords:  Diabetes mellitus; Hormone replacement therapy; Hypercalcemia; Hypertension; Osteoporosis

Mesh:

Year:  2016        PMID: 27233786     DOI: 10.1007/s00108-016-0072-4

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  34 in total

1.  Toward excellence in testosterone testing: a consensus statement.

Authors:  William Rosner; Hubert Vesper
Journal:  J Clin Endocrinol Metab       Date:  2010-10       Impact factor: 5.958

2.  Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations.

Authors:  E Nieschlag; R Swerdloff; H M Behre; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; J E Morley; C Schulman; C Wang; W Weidner; F C W Wu
Journal:  Eur Urol       Date:  2005-07       Impact factor: 20.096

3.  Thyroid Hormone Therapy and Risk of Thyrotoxicosis in Community-Resident Older Adults: Findings from the Baltimore Longitudinal Study of Aging.

Authors:  Jennifer S Mammen; John McGready; Rachael Oxman; Chee W Chia; Paul W Ladenson; Eleanor M Simonsick
Journal:  Thyroid       Date:  2015-08-13       Impact factor: 6.568

4.  Korea's thyroid-cancer "epidemic"--screening and overdiagnosis.

Authors:  Hyeong Sik Ahn; Hyun Jung Kim; H Gilbert Welch
Journal:  N Engl J Med       Date:  2014-11-06       Impact factor: 91.245

5.  Geographic variations in the frequency of thyroid disorders and thyroid peroxidase antibodies in persons without former thyroid disease within Germany.

Authors:  C Meisinger; T Ittermann; H Wallaschofski; M Heier; H Below; A Kramer; A Döring; M Nauck; H Völzke
Journal:  Eur J Endocrinol       Date:  2012-06-13       Impact factor: 6.664

6.  Observational study mortality in treated primary aldosteronism: the German Conn's registry.

Authors:  Martin Reincke; Evelyn Fischer; Sabine Gerum; Katrin Merkle; Sebastian Schulz; Anna Pallauf; Marcus Quinkler; Gregor Hanslik; Katharina Lang; Stefanie Hahner; Bruno Allolio; Christa Meisinger; Rolf Holle; Felix Beuschlein; Martin Bidlingmaier; Stephan Endres
Journal:  Hypertension       Date:  2012-07-23       Impact factor: 10.190

7.  The epidemiology of osteoporosis--Bone Evaluation Study (BEST): an analysis of routine health insurance data.

Authors:  Peyman Hadji; Silvia Klein; Holger Gothe; Bertram Häussler; Thomas Kless; Torsten Schmidt; Thomas Steinle; Frank Verheyen; Roland Linder
Journal:  Dtsch Arztebl Int       Date:  2013-01-25       Impact factor: 5.594

8.  The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies.

Authors:  Cathleen Colón-Emeric; Maragatha Kuchibhatla; Carl Pieper; William Hawkes; Lisa Fredman; Jay Magaziner; Sheryl Zimmerman; Kenneth W Lyles
Journal:  Osteoporos Int       Date:  2003-10-03       Impact factor: 4.507

9.  Reduction of thyroid nodule volume by levothyroxine and iodine alone and in combination: a randomized, placebo-controlled trial.

Authors:  M Grussendorf; C Reiners; R Paschke; K Wegscheider
Journal:  J Clin Endocrinol Metab       Date:  2011-06-29       Impact factor: 5.958

10.  Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon Longitudinal Study of Parents and Children (ALSPAC).

Authors:  Sarah C Bath; Colin D Steer; Jean Golding; Pauline Emmett; Margaret P Rayman
Journal:  Lancet       Date:  2013-05-22       Impact factor: 79.321

View more
  1 in total

Review 1.  [Response to and further development of the Choosing wisely initiative].

Authors:  U R Fölsch; M Hallek; T Raupach; G Hasenfuß
Journal:  Internist (Berl)       Date:  2017-06       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.